Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
A Hill, B Simmons, D Gotham, et al.
Read MoreSubject
Issues
Volume 2 1
NIAID
Treatment outcomes of first-line antiretroviral therapy in HIV-1-positive patients in Serbia
J Kušic, M Mladenovic, B Dimitrijevic, et al.
Read More
NIAID
Factors associated with HIV RNA viral loads in ART-naïve patients: implications for treatment as prevention in concentrated epidemics
S Rangarajan, D Colby, G Le Truong, et al.
Read More
NIAID
Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection
J Ananworanich, CP Sacdalan, S Pinyakorn, et al.
Read More
Women in HIV cure research: multilevel interventions to improve sex equity in recruitment
ME Grewe, Y Ma, A Gilbertson, et al.
Read More
CDC/A Williams
Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland
K Aebi-Popp, A Duppenthaler, A Rauch, et al.
Read More